18-66504951-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_021153.4(CDH19):c.2180G>T(p.Gly727Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000738 in 1,613,398 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0036 ( 9 hom., cov: 31)
Exomes 𝑓: 0.00044 ( 3 hom. )
Consequence
CDH19
NM_021153.4 missense
NM_021153.4 missense
Scores
7
7
4
Clinical Significance
Conservation
PhyloP100: 7.41
Genes affected
CDH19 (HGNC:1758): (cadherin 19) This gene is one of three related type II cadherin genes situated in a cluster on chromosome 18. The encoded protein is a calcium dependent cell-cell adhesion glycoprotein containing five extracellular cadherin repeats. Loss of cadherins may be associated with cancer formation. Alternative splicing results in multiple transcript variants for this gene. [provided by RefSeq, Aug 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.019753516).
BP6
Variant 18-66504951-C-A is Benign according to our data. Variant chr18-66504951-C-A is described in ClinVar as [Benign]. Clinvar id is 3052874.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Homozygotes in GnomAd4 at 9 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDH19 | NM_021153.4 | c.2180G>T | p.Gly727Val | missense_variant | 12/12 | ENST00000262150.7 | NP_066976.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDH19 | ENST00000262150.7 | c.2180G>T | p.Gly727Val | missense_variant | 12/12 | 1 | NM_021153.4 | ENSP00000262150.2 | ||
CDH19 | ENST00000579658.5 | n.*526G>T | non_coding_transcript_exon_variant | 12/12 | 1 | ENSP00000463085.1 | ||||
CDH19 | ENST00000579658.5 | n.*526G>T | 3_prime_UTR_variant | 12/12 | 1 | ENSP00000463085.1 |
Frequencies
GnomAD3 genomes AF: 0.00363 AC: 551AN: 151938Hom.: 9 Cov.: 31
GnomAD3 genomes
AF:
AC:
551
AN:
151938
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00107 AC: 268AN: 250638Hom.: 1 AF XY: 0.000805 AC XY: 109AN XY: 135464
GnomAD3 exomes
AF:
AC:
268
AN:
250638
Hom.:
AF XY:
AC XY:
109
AN XY:
135464
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000439 AC: 641AN: 1461342Hom.: 3 Cov.: 31 AF XY: 0.000403 AC XY: 293AN XY: 726978
GnomAD4 exome
AF:
AC:
641
AN:
1461342
Hom.:
Cov.:
31
AF XY:
AC XY:
293
AN XY:
726978
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00362 AC: 550AN: 152056Hom.: 9 Cov.: 31 AF XY: 0.00336 AC XY: 250AN XY: 74322
GnomAD4 genome
AF:
AC:
550
AN:
152056
Hom.:
Cov.:
31
AF XY:
AC XY:
250
AN XY:
74322
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
51
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
150
Asia WGS
AF:
AC:
2
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
CDH19-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 25, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
H
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Pathogenic
Sift
Uncertain
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at